Temozolomide for malignant brain tumours

This publication has 7 references indexed in Scilit:

• A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide: A North American Brain Tumor Consortium study
  Neuro-Oncology, 2000
• Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse
  Journal of Clinical Oncology, 1999
• DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma.
  Journal of Clinical Oncology, 1998
• Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma
  Cancer Chemotherapy and Pharmacology, 1997
• Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials
  Published by Elsevier ,1997
• The charing cross hospital experience with temozolomide in patients with gliomas
  European Journal Of Cancer, 1996
• O6-benzylguanine enhances the sensitivity of a glioma xenograft with low O6-alkylguanine-DNA alkyltransferase activity to temozolomide and BCNU
  British Journal of Cancer, 1996